Researchers are exploring dna-based immunotherapy for cancer, focusing on in vivo approaches to address challenging targets. This approach aims to tackle cancer in a new way, using the body's own immune system. The development of such treatments is being investigated for their potential to combat difficult-to-treat cancers.